Markets › United States › NAS › KZIA

Kazia Therapeutics Ltd

NAS:KZIAHealthcarenasdaq_composite

$7.93+0.96%LiveIn session · ≈ AED 29.10 · Market cap $83.64M · Next earnings Tue 2 Mar

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	—	—
Operating margin	−1,234.3%	−42.0%	−253,990.0%	−4,346,661.1%	−1,233.2%	−33,850.0%	−33,850.0%	+0.0 pts
Net margin	−1,261.7%	−55.5%	−250,140.0%	−3,687,419.8%	−1,160.2%	−49,290.5%	−49,290.5%	+0.0 pts
EBITDA margin	−1,124.3%	−33.7%	−235,150.0%	−4,013,885.9%	−1,152.2%	−31,626.2%	—	—
Return on equity	−88.3%	−22.2%	−136.9%	−169.8%	267.3%	249.4%	249.4%	+0.0 pts
Return on assets	−54.1%	−14.5%	−69.7%	−72.9%	−124.1%	−341.6%	−341.6%	+0.0 pts
Return on capital employed	−67.8%	−12.8%	−87.1%	−117.6%	675.7%	177.9%	—	—
Debt / equity	0.0×	0.0×	0.1×	0.1×	−0.1×	−0.0×	−0.0×	+0.0%
Debt / assets	0.0%	0.0%	5.1%	6.4%	2.9%	6.5%	—	—
Interest coverage	0.0×	0.0×	−12,129.4×	0.0×	0.0×	0.0×	—	—
Current ratio	2.1×	3.5×	1.4×	1.4×	0.2×	0.4×	0.4×	+0.0%
Quick ratio	2.1×	3.5×	1.4×	1.4×	0.2×	0.4×	—	—
Cash ratio	1.7×	3.3×	1.1×	0.7×	0.1×	0.3×	0.3×	+0.0%
Asset turnover	0.0×	0.3×	0.0×	0.0×	0.1×	0.0×	—	—
Receivables turnover	2,250.8×	—	0.2×	0.0×	17.4×	0.5×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—